Arkolith/Insider Trading/TPST/Form 4

Angel Matthew

CEO and President, Director, 10% OwnerTempest Therapeutics, Inc. (TPST) · full profile →Form 4 · filed Mar 25, 2026
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Buy(P)231K$2.16$500K231K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001931356-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML